1-8 of 8
Colin C. Collins
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer

Amilcar Flores-Morales, Tobias B. Bergmann, Charlotte Lavallee, Tanveer S. Batth, Dong Lin, Mads Lerdrup, Stine Friis, Anette Bartels, Gitte Kristensen, Agnieszka Krzyzanowska, Hui Xue, Ladan Fazli, Klaus H. Hansen, Martin A. Røder, Klaus Brasso, José M. Moreira, Anders Bjartell, Yuzhuo Wang, Jesper V. Olsen, Colin C. Collins, Diego Iglesias-Gato
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (2): 595–608.
https://doi.org/10.1158/1078-0432.CCR-18-0729
Published: 15 January 2019
View article titled, Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer
Open the PDF for Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Mutational Analysis of Gene Fusions Predicts Novel MHC Class I–Restricted T-Cell Epitopes and Immune Signatures in a Subset of Prostate Cancer

Jennifer L. Kalina, David S. Neilson, Yen-Yi Lin, Phineas T. Hamilton, Alexandra P. Comber, Emma M.H. Loy, S. Cenk Sahinalp, Colin C. Collins, Faraz Hach, Julian J. Lum
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (24): 7596–7607.
https://doi.org/10.1158/1078-0432.CCR-17-0618
Published: 14 December 2017
View article titled, Mutational Analysis of Gene Fusions Predicts Novel MHC Class I–Restricted T-Cell Epitopes and Immune Signatures in a Subset of Prostate Cancer
Open the PDF for Mutational Analysis of Gene Fusions Predicts Novel MHC Class I–Restricted T-Cell Epitopes and Immune Signatures in a Subset of Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy

Himisha Beltran, Alexander W. Wyatt, Edmund C. Chedgy, Adam Donoghue, Matti Annala, Evan W. Warner, Kevin Beja, Michael Sigouros, Fan Mo, Ladan Fazli, Colin C. Collins, James Eastham, Michael Morris, Mary-Ellen Taplin, Andrea Sboner, Susan Halabi, Martin E. Gleave
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (22): 6802–6811.
https://doi.org/10.1158/1078-0432.CCR-17-1034
Published: 14 November 2017
View article titled, Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy
Open the PDF for Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy in another window
Includes: Supplementary data
Journal Articles

Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer

Gillian Vandekerkhove, Tilman Todenhöfer, Matti Annala, Werner J. Struss, Amanda Wong, Kevin Beja, Elie Ritch, Sonal Brahmbhatt, Stanislav V. Volik, Jörg Hennenlotter, Matti Nykter, Kim N. Chi, Scott North, Arnulf Stenzl, Colin C. Collins, Bernhard J. Eigl, Peter C. Black, Alexander W. Wyatt
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (21): 6487–6497.
https://doi.org/10.1158/1078-0432.CCR-17-1140
Published: 31 October 2017
View article titled, Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer
Open the PDF for Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer in another window
Includes: Supplementary data
Journal Articles

BIRC6 Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer

Iris Sze Ue Luk, Raunak Shrestha, Hui Xue, Yuwei Wang, Fang Zhang, Dong Lin, Anne Haegert, Rebecca Wu, Xin Dong, Colin C. Collins, Amina Zoubeidi, Martin E. Gleave, Peter W. Gout, Yuzhuo Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (6): 1542–1551.
https://doi.org/10.1158/1078-0432.CCR-16-0718
Published: 14 March 2017
View article titled, <em>BIRC6</em> Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer
Open the PDF for <em>BIRC6</em> Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

The MCT4 Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer

Stephen Yiu Chuen Choi, Hui Xue, Rebecca Wu, Ladan Fazli, Dong Lin, Colin C. Collins, Martin E. Gleave, Peter W. Gout, Yuzhuo Wang
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (11): 2721–2733.
https://doi.org/10.1158/1078-0432.CCR-15-1624
Published: 31 May 2016
View article titled, The <em>MCT4</em> Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer
Open the PDF for The <em>MCT4</em> Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer

Arun A. Azad, Stanislav V. Volik, Alexander W. Wyatt, Anne Haegert, Stephane Le Bihan, Robert H. Bell, Shawn A. Anderson, Brian McConeghy, Robert Shukin, Jenny Bazov, Jack Youngren, Pamela Paris, George Thomas, Eric J. Small, Yuzhuo Wang, Martin E. Gleave, Colin C. Collins, Kim N. Chi
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (10): 2315–2324.
https://doi.org/10.1158/1078-0432.CCR-14-2666
Published: 14 May 2015
View article titled, Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer
Open the PDF for Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Generation 2.5 Antisense Oligonucleotides Targeting the Androgen Receptor and Its Splice Variants Suppress Enzalutamide-Resistant Prostate Cancer Cell Growth

Yoshiaki Yamamoto, Yohann Loriot, Eliana Beraldi, Fan Zhang, Alexander W. Wyatt, Nader Al Nakouzi, Fan Mo, Tianyuan Zhou, Youngsoo Kim, Brett P. Monia, A. Robert MacLeod, Ladan Fazli, Yuzhuo Wang, Colin C. Collins, Amina Zoubeidi, Martin Gleave
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (7): 1675–1687.
https://doi.org/10.1158/1078-0432.CCR-14-1108
Published: 31 March 2015
View article titled, Generation 2.5 Antisense Oligonucleotides Targeting the Androgen Receptor and Its Splice Variants Suppress Enzalutamide-Resistant Prostate Cancer Cell Growth
Open the PDF for Generation 2.5 Antisense Oligonucleotides Targeting the Androgen Receptor and Its Splice Variants Suppress Enzalutamide-Resistant Prostate Cancer Cell Growth in another window
Includes: Supplementary data